Trending/Dr. Vincent Rajkumar
Lenalidomide may delay onset of myeloma-related bone, organ damage
ROCHESTER Minn. — The largest randomized trial in asymptomatic patients with smoldering multiple myeloma suggests that lenalidomide, a cancer drug, may delay the onset of…
May 12, 2019
November 14, 2018
November 2, 2016
Special Topics
Sign up
Mayo Clinic Connect
An online patient support community